Theralase Technologies Inc. V.TLT

Oversight

[Bunge]

Will they ever end?

Those 4 could have counted?

[CAinPlap]

On the glass half full side, the delays have allowed us to identify the misstakes made and correct them. It would have really sucked if we had been treating patients in US and had treated half the expected participants before they discovered the deficiencies in the process.  Dodged a bullet is right whoever said that. Also agree we need to add another year to our timeline. Hurry up and wait

[Pandora]

Problem is, as the old saying goes, excuses are for losers.

[Quattro74]

Well, this wont get us to fasttrack designation soon, as we'd hoped. Yet I can't help but think the market will look more closely at the second 50, IF 100 get in the study, vs the first 50. Or perhaps at the second 25 if it is only 50. That they will factor in the Covid mess as potentially messing early study performance up to some degree. IF the %s improve dramatically from here we will